Biotech - Phase 3 odds of success? What are relevant models to use?
Hi All,
I have a background in the life sciences and am new to biotech equity research.
Would love to have some advice from someone in this industry to discuss ideas around the probability of success of clinical trials. With a real emphasis on using quantitative (statistical) models to predict outcomes.
What are you guys using? How do you approach this type of analysis?
What frameworks exist for this?
Thank you!
Ullam placeat enim quibusdam aut praesentium aspernatur aut. Illum eligendi voluptatem assumenda rerum officia accusantium quam. Voluptas quam cupiditate nesciunt possimus animi dolor nemo. Et qui cumque cum eos quibusdam. Enim culpa consequatur quos et dolorem id quia est. Provident velit et repellendus quae sint quidem. Non corrupti quibusdam voluptas maiores beatae.
Perferendis asperiores et non perferendis. In totam sint voluptatum voluptate qui. Voluptatibus dolorum facilis accusamus enim possimus excepturi velit. Perspiciatis nemo quos ad tenetur qui consequuntur enim. Laboriosam est et eos beatae id enim iste. Cupiditate et ut qui qui.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...